Owens & Minor (NYSE:OMI) Updates FY 2025 Earnings Guidance

Owens & Minor (NYSE:OMI - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 1.600-1.850 for the period, compared to the consensus EPS estimate of 1.790. The company issued revenue guidance of $10.9 billion-$11.2 billion, compared to the consensus revenue estimate of $11.0 billion. Owens & Minor also updated its FY25 guidance to $1.60-1.85 EPS.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on OMI. Citigroup dropped their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Barclays dropped their price target on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a research note on Tuesday, November 5th. Robert W. Baird upped their price objective on Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research report on Monday. Finally, UBS Group dropped their target price on Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $15.08.

Owens & Minor Stock Up 4.7 %

Shares of Owens & Minor stock traded up $0.44 during trading hours on Tuesday, reaching $9.76. 4,000,581 shares of the company's stock were exchanged, compared to its average volume of 1,716,829. The stock has a market cap of $752.66 million, a P/E ratio of -15.02, a P/E/G ratio of 0.20 and a beta of 0.48. The company has a 50 day moving average of $11.44 and a two-hundred day moving average of $13.18. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $28.35.

Remove Ads

Owens & Minor (NYSE:OMI - Get Free Report) last issued its quarterly earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion during the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business's quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.69 earnings per share. On average, sell-side analysts forecast that Owens & Minor will post 1.51 EPS for the current fiscal year.

Owens & Minor declared that its Board of Directors has authorized a share buyback program on Friday, February 28th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 13.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.